The CRN aims to:
Advance and promote quality clinical infectious diseases research.

Foster a network of local and international experts.

Design, conduct and publish clinically relevant, evidence-based infectious diseases research.

Build an effective research network that rapidly responds to evolving infectious diseases threats.

Build links and collaborations with similar groups in Australia, New Zealand and overseas.

CRN educational activities include:

An Annual meeting highlighting current research breaking new ground in infectious diseases.

A CRN Symposia at the ASID Annual Scientific Meeting.

Committee:
Chair: Prof Jason Trubiano
Members: Prof Steven Tong, A/Prof Asha Bowen, Dr Ameneh Khatami, Prof Joe Doyle, Dr J Hanson, Dr S Morpeth, Dr J Lau, Assoc Prof Gail Matthews.
Co-opted SIG Members:
Prof O Morrissey (ANZMIG)
Dr Ameneh Khatami (ANZPID)
Dr Sophie Wen (VACSIG)
Dr Jason Kwong (HICSIG)
Dr Ben Teh (ICHSIG)
Dr Sushena Krishnaswamy (VHSIG)
Dr Kathryn Wilks (ZOOSIG)

2022

Invasive Staphylococcus aureus infections and hospitalisations in Australian and New Zealand children (ISAIAH).

2021

Pre-school osteoarticular infection (POI) study.

Pre 2019

Overview of paediatric tuberculosis cases treated in the Sydney Children’s Hospitals Network, Australia

Spectrum of Disease in Children Treated for Tuberculosis at a Tertiary Children's Hospital in Australia

BALANCE Plus: Platform trial for Gram Negative Bloodstream Infection

Australian Project Lead: A/Prof Ben Rogers, Monash University

Global Leads: Dr Nick Daneman and Dr Rob Fowler

BALANCE Plus is foundational multi-domain adaptive platform trial of treatment strategies for gram-negative blood-stream infection. It has an open-label pragmatic design. Launch domains include cross-cutting and sub-group focused questions.

Endorsed: April 2024

International Network of Antibiotic Allergy Nations (iNAAN)

Chief Principal Investigator: Prof Jason Trubiano

Associate Investigators: A/Prof Natasha Holmes, Dr Kyra Chua Ms Fiona James, Ms Elise Mitri (Project Manager)

App Developer: Dr Luke Fletcher
BioGrid Australia - CEO: Ms Maureen Turner

The iNAAN study seeks to improve access to penicillin allergy assessment and direct oral penicillin challenge procedures for hospitalised patients with a penicillin allergy to improve antimicrobial prescribing and reduce antimicrobial resistance and negative health service outcomes.

Endorsed: October 2023

ANZPID studies: As at July 2023.

The primary focus of our clinician-initiated research is to answer problems of direct clinical relevance. The impact of clinician-focused research within the ASID CRN is aimed at improving direct patient outcomes, facilitating physician effectiveness and providing valuable cost-savings to the health care system.

If you are an ASID member seeking endorsement from the ASID CRN , please fill out the Endorsement Request Form and email it to submissions@asid.net.au.

See an example of the level of study detail required (around two pages long).

Please allow up to four weeks for your request to be reviewed.

NOTE: For paediatric only studies, or for joint adult and paediatric studies where separate paediatric review is desirable, please complete the ANZPID Research Project Submission Form and email to submissions@asid.net.au. ANZPID endorsed studies are by default also ASID CRN endorsed and will be listed as such.